Ovoca Bio | OVG - Operating Expenses


Ovoca Bio reported EUR5.65M in Operating Expenses for its fiscal semester ending in June of 2022.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
ALKERMES USD 1.73B 1.44B Sep/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Great Western Mining Corporation EUR 529.86K 27.43K Jun/2023
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Viatris USD 3.53B 128.7M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025